ArticleMaterials (Basel, Switzerland)2024
Experimental Study to Investigate the Performance-Related Properties of Modified Asphalt Concrete Using Nanomaterials Al
Article in Materials (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- High-Temperature Properties of Hot Mix Asphalt Modified with Different Nanomaterials.Nanomaterials (Basel, Switzerland) · 2025Article
- A State-of-the-Practice Review on the Challenges of Asphalt Binder and a Roadmap Towards Sustainable Alternatives-A Call to Action.Materials (Basel, Switzerland) · 2025Review
- Analysis of the Optimum Performance for Polymer and Polymer-Nanocomposite-modified Asphalt by Using Multicriteria Decision Analysis.Polymers · 2024Article
- Nanomaterials for Modified Asphalt and Their Effects on Viscosity Characteristics: A Comprehensive Review.Nanomaterials (Basel, Switzerland) · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The dual nature of asphalt binder necessitates improvements to mitigate rutting and fatigue since it performs as an elastic material under the regime of rapid loading or cold temperatures and as a viscous fluid at elevated temperatures. The present investigation assesses the effectiveness of Nano Alumina (NA), Nano Silica (NS), and Nano Titanium Dioxide (NT) at weight percentages of 0, 2, 4, 6, and 8% in asphalt cement to enhance both asphalt binder and mixture performance. Binder evaluations include tests for consistency, thermal susceptibility, aging, and workability, while mixture assessments focus on Marshall properties, moisture susceptibility, resilient modulus, permanent deformation, and fatigue characteristics. NS notably improves binder viscosity by about 138% and reduces penetration by approximately 40.8% at 8% nanomaterial (NM) content, significantly boosting hardness and consistency. NS also enhances Marshall stability and decreases air voids, increasing the mix's durability. For moisture resistance, NS at 8% NM content elevates the Tensile Strength Ratio (TSR) to 91.0%, substantially surpassing the 80% standard. Similarly, NA and NT also show improved TSR values at 8% NM content, with 88.0% and 84.1%, respectively. Additionally, NS, NA, and NT reduce permanent deformation by 82%, 69%, and 64% at 10,000 cycles at 8% NM content, illustrating their effectiveness in mitigating pavement distress. Notably, while higher NM content generally results in better performance across most tests, the optimal NM content for fatigue resistance is 4% for NS and 6% for both NA and NT, reflecting their peak performance against various types of pavement distresses. These results highlight the significant advantages of nanoparticles in improving asphalt's mechanical properties, workability, stability, and durability. The study recommends further field validation to confirm these laboratory findings and ensure that enhancements translate into tangible improvements in real-world pavement performance and longevity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.